The Role of Uric Acid in Hypertension of Adolescents, Prehypertension and Salt Sensitivity of Blood Pressure. 2017

Yang Wang, and Jia-Wen Hu, and Yong-Bo Lv, and Chao Chu, and Ke-Ke Wang, and Wen-Ling Zheng, and Yu-Meng Cao, and Zu-Yi Yuan, and Jian-Jun Mu
Department of Cardiology, First Affiliated Hospital of Medical School, Xi'an Jiaotong University, Xi'an, Shaanxi, China (mainland).

Uric acid is the end product of purine metabolism. Metabolic disorders of uric acid are associated with many disease states. Substantial evidence suggests the possible role of uric acid as a mediator of high blood pressure. Elevated uric acid is closely associated with new onset essential hypertension in adolescents and prehypertension; and urate-lowering agents can significantly improve these early stages of hypertension. Uric acid also influences salt sensitivity of blood pressure through two phases. Local renin-angiotensin-aldosterone system activation initiates renal damage, arteriolopathy, and endothelium dysfunction, which is followed by the dysregulation of sodium homeostasis, thereby leading to increased salt sensitivity. In this review we summarize the available evidence to contribute to a better understanding of the casual relationship between uric acid and early or intermediate stages of hypertension. We hope our review can contribute to the prevention of hypertension or provide new insights into a treatment that would slow the progression of hypertension.

UI MeSH Term Description Entries
D006973 Hypertension Persistently high systemic arterial BLOOD PRESSURE. Based on multiple readings (BLOOD PRESSURE DETERMINATION), hypertension is currently defined as when SYSTOLIC PRESSURE is consistently greater than 140 mm Hg or when DIASTOLIC PRESSURE is consistently 90 mm Hg or more. Blood Pressure, High,Blood Pressures, High,High Blood Pressure,High Blood Pressures
D001794 Blood Pressure PRESSURE of the BLOOD on the ARTERIES and other BLOOD VESSELS. Systolic Pressure,Diastolic Pressure,Pulse Pressure,Pressure, Blood,Pressure, Diastolic,Pressure, Pulse,Pressure, Systolic,Pressures, Systolic
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000075222 Essential Hypertension Hypertension that occurs without known cause, or preexisting renal disease. Associated polymorphisms for a number of genes have been identified, including AGT, GNB3, and ECE1. OMIM: 145500 Primary Hypertension,Hypertension, Essential,Hypertension, Primary,Hypertensions, Primary,Primary Hypertensions
D000293 Adolescent A person 13 to 18 years of age. Adolescence,Youth,Adolescents,Adolescents, Female,Adolescents, Male,Teenagers,Teens,Adolescent, Female,Adolescent, Male,Female Adolescent,Female Adolescents,Male Adolescent,Male Adolescents,Teen,Teenager,Youths
D000367 Age Factors Age as a constituent element or influence contributing to the production of a result. It may be applicable to the cause or the effect of a circumstance. It is used with human or animal concepts but should be differentiated from AGING, a physiological process, and TIME FACTORS which refers only to the passage of time. Age Reporting,Age Factor,Factor, Age,Factors, Age
D012965 Sodium Chloride A ubiquitous sodium salt that is commonly used to season food. Sodium Chloride, (22)Na,Sodium Chloride, (24)NaCl
D014527 Uric Acid An oxidation product, via XANTHINE OXIDASE, of oxypurines such as XANTHINE and HYPOXANTHINE. It is the final oxidation product of purine catabolism in humans and primates, whereas in most other mammals URATE OXIDASE further oxidizes it to ALLANTOIN. 2,6,8-Trihydroxypurine,Ammonium Acid Urate,Monosodium Urate,Monosodium Urate Monohydrate,Potassium Urate,Sodium Acid Urate,Sodium Acid Urate Monohydrate,Sodium Urate,Sodium Urate Monohydrate,Trioxopurine,Urate,Acid Urate, Ammonium,Acid Urate, Sodium,Acid, Uric,Monohydrate, Monosodium Urate,Monohydrate, Sodium Urate,Urate Monohydrate, Monosodium,Urate Monohydrate, Sodium,Urate, Ammonium Acid,Urate, Monosodium,Urate, Potassium,Urate, Sodium,Urate, Sodium Acid
D017673 Sodium Chloride, Dietary Sodium chloride used in foods. Dietary Sodium Chloride,Table Salt,Chloride, Dietary Sodium,Salt, Table
D058246 Prehypertension Blood pressure levels that are between normotension and hypertension. Individuals with prehypertension are at a higher risk for developing cardiovascular diseases. Generally, prehypertension is defined as SYSTOLIC PRESSURE of 131-139 mm Hg and/or DIASTOLIC PRESSURE of 81-89 when the optimal is 120/80 mm Hg. For diabetics and other metabolism diseases the prehypertension is around 110-129/70-79 mm Hg. Pre-Hypertension,Pre Hypertension,Pre-Hypertensions,Prehypertensions

Related Publications

Yang Wang, and Jia-Wen Hu, and Yong-Bo Lv, and Chao Chu, and Ke-Ke Wang, and Wen-Ling Zheng, and Yu-Meng Cao, and Zu-Yi Yuan, and Jian-Jun Mu
January 2012, Adolescent health, medicine and therapeutics,
Yang Wang, and Jia-Wen Hu, and Yong-Bo Lv, and Chao Chu, and Ke-Ke Wang, and Wen-Ling Zheng, and Yu-Meng Cao, and Zu-Yi Yuan, and Jian-Jun Mu
November 2012, Hypertension (Dallas, Tex. : 1979),
Yang Wang, and Jia-Wen Hu, and Yong-Bo Lv, and Chao Chu, and Ke-Ke Wang, and Wen-Ling Zheng, and Yu-Meng Cao, and Zu-Yi Yuan, and Jian-Jun Mu
July 2022, Nutrition, metabolism, and cardiovascular diseases : NMCD,
Yang Wang, and Jia-Wen Hu, and Yong-Bo Lv, and Chao Chu, and Ke-Ke Wang, and Wen-Ling Zheng, and Yu-Meng Cao, and Zu-Yi Yuan, and Jian-Jun Mu
January 2005, Seminars in nephrology,
Yang Wang, and Jia-Wen Hu, and Yong-Bo Lv, and Chao Chu, and Ke-Ke Wang, and Wen-Ling Zheng, and Yu-Meng Cao, and Zu-Yi Yuan, and Jian-Jun Mu
January 1993, Annals of human biology,
Yang Wang, and Jia-Wen Hu, and Yong-Bo Lv, and Chao Chu, and Ke-Ke Wang, and Wen-Ling Zheng, and Yu-Meng Cao, and Zu-Yi Yuan, and Jian-Jun Mu
October 2017, Journal of hypertension,
Yang Wang, and Jia-Wen Hu, and Yong-Bo Lv, and Chao Chu, and Ke-Ke Wang, and Wen-Ling Zheng, and Yu-Meng Cao, and Zu-Yi Yuan, and Jian-Jun Mu
January 1990, Journal of cardiovascular pharmacology,
Yang Wang, and Jia-Wen Hu, and Yong-Bo Lv, and Chao Chu, and Ke-Ke Wang, and Wen-Ling Zheng, and Yu-Meng Cao, and Zu-Yi Yuan, and Jian-Jun Mu
April 2024, Current hypertension reports,
Yang Wang, and Jia-Wen Hu, and Yong-Bo Lv, and Chao Chu, and Ke-Ke Wang, and Wen-Ling Zheng, and Yu-Meng Cao, and Zu-Yi Yuan, and Jian-Jun Mu
January 2022, Frontiers in cardiovascular medicine,
Yang Wang, and Jia-Wen Hu, and Yong-Bo Lv, and Chao Chu, and Ke-Ke Wang, and Wen-Ling Zheng, and Yu-Meng Cao, and Zu-Yi Yuan, and Jian-Jun Mu
January 2017, Clinical and experimental hypertension (New York, N.Y. : 1993),
Copied contents to your clipboard!